We expect the company's EPS for 2012-2014 to be 0.12 yuan, 0.26 yuan, and 0.65 yuan, respectively. Currently, most of the company's profits come from traditional business, but starting this year, the new polyimide materials business has taken a big step from successful trial production to large-scale commercialization. It has begun to release production capacity and contribute to performance. There is huge room for future market growth, so it is worth looking forward to, giving the company a rating to increase its holdings.
【国海证券】深圳惠程深度报告:聚酰亚胺产业化已见成效,值得期待
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.